Terms: = Ovarian cancer AND HOXD13, SPD, 3239, P35453, HOX4I
12 results:
1. Clinical and Prognostic Value of Antigen-Presenting Cells with PD-L1/PD-L2 Expression in ovarian cancer Patients.
Pawłowska A; Kwiatkowska A; Suszczyk D; Chudzik A; Tarkowski R; Barczyński B; Kotarski J; Wertel I
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768993
[TBL] [Abstract] [Full Text] [Related]
2. Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in ovarian cancer.
Miao YR; Thakkar KN; Qian J; Kariolis MS; Huang W; Nandagopal S; Yang TTC; Diep AN; Cherf GM; Xu Y; Moon EJ; Xiao Y; Alemany H; Li T; Yu W; Wei B; Rankin EB; Giaccia AJ
Clin Cancer Res; 2021 Aug; 27(15):4435-4448. PubMed ID: 34011561
[TBL] [Abstract] [Full Text] [Related]
3. Soluble forms of immune checkpoints in ovarian cancer.
Kovaleva OV; Belova TP; Kushlinsky DN; Korotkova EA; Podlesnaya PA; Gratchev AN; Zinoviev SV; Tereshkina IV; Sokolov NY; Kudlay DA; Kushlinskii NE
Klin Lab Diagn; 2021 Mar; 66(2):80-86. PubMed ID: 33734640
[TBL] [Abstract] [Full Text] [Related]
4. [Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in ovarian cancer].
Kushlinskii NE; Loginov VI; Utkin DO; Filippova EA; Burdennyy AM; Korotkova EA; Pronina IV; Lukina SS; Smirnova AV; Gershtein ES; Braga EA
Mol Biol (Mosk); 2020; 54(6):990-996. PubMed ID: 33276362
[TBL] [Abstract] [Full Text] [Related]
5. Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.
Okła K; Rajtak A; Czerwonka A; Bobiński M; Wawruszak A; Tarkowski R; Bednarek W; Szumiło J; Kotarski J
J Transl Med; 2020 Jun; 18(1):220. PubMed ID: 32487171
[TBL] [Abstract] [Full Text] [Related]
6. Increased Soluble PD-L1 Levels in the Plasma of Patients with Epithelial ovarian cancer Correlate with Plasma Levels of
Koukourakis MI; Kontomanolis E; Sotiropoulou M; Mitrakas A; Dafa E; Pouliliou S; Sivridis E; Giatromanolaki A
Anticancer Res; 2018 Oct; 38(10):5739-5745. PubMed ID: 30275195
[TBL] [Abstract] [Full Text] [Related]
7. Pathological Significance and Prognostic Value of Surfactant Protein D in cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract] [Full Text] [Related]
8. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.
Shiels MS; Chaturvedi AK; Katki HA; Gochuico BR; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2262-72. PubMed ID: 21828236
[TBL] [Abstract] [Full Text] [Related]
9. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
Kajiyama H; Shibata K; Suzuki S; Ino K; Yamamoto E; Mizuno K; Sakakibara K; Matsuzawa K; Takeda A; Kinoshita Y; Kawai M; Nagasaka T; Nawa A; Kikkawa F
Gynecol Oncol; 2008 Dec; 111(3):523-6. PubMed ID: 18538833
[TBL] [Abstract] [Full Text] [Related]
10. N1,N12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines.
Marverti G; Piccinini G; Ghiaroni S; Barbieri D; Quaglino D; Moruzzi MS
Int J Cancer; 1998 Sep; 78(1):33-40. PubMed ID: 9724091
[TBL] [Abstract] [Full Text] [Related]
11. Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells.
Marverti G; Andrews PA; Piccinini G; Ghiaroni S; Barbieri D; Moruzzi MS
Eur J Cancer; 1997 Apr; 33(4):669-75. PubMed ID: 9274452
[TBL] [Abstract] [Full Text] [Related]
12. [The evaluation of ovarian tumor associated with pregnancy by the ultrasonographical method and serum CA125 levels].
Fujishita A; Masuzaki H; Nakajima H; Ishimaru T; Yamabe T
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Sep; 46(9):875-82. PubMed ID: 7963887
[TBL] [Abstract] [Full Text] [Related]
